| Literature DB >> 32188978 |
Gabriele Andrea Lugli1, Sabrina Duranti1, Christian Milani1, Leonardo Mancabelli1, Francesca Turroni1,2, Giulia Alessandri3, Giulia Longhi4, Rosaria Anzalone4, Alice Viappinai4, Chiara Tarracchini1, Sergio Bernasconi2, Chloe Yonemitsu5, Lars Bode5, Michael I Goran6, Maria Cristina Ossiprandi3, Douwe van Sinderen7, Marco Ventura1,2.
Abstract
Human milk is known to carry its own microbiota, of which the precise origin remains obscure. Breastfeeding allows mother-to-baby transmission of microorganisms as well as the transfer of many other milk components, such as human milk oligosaccharides (HMOs), which act as metabolizable substrates for particular bacteria, such as bifidobacteria, residing in infant intestinal tract. In the current study, we report the HMO composition of 249 human milk samples, in 163 of which we quantified the abundance of members of the Bifidobacterium genus using a combination of metagenomic and flow cytometric approaches. Metagenomic data allowed us to identify four clusters dominated by Bifidobacterium adolescentis and Bifidobacterium pseudolongum, Bifidobacterium crudilactis or Bifidobacterium dentium, as well as a cluster represented by a heterogeneous mix of bifidobacterial species such as Bifidobacterium breve and Bifidobacterium longum. Furthermore, in vitro growth assays on HMOs coupled with in silico glycobiome analyses allowed us to elucidate that members of the Bifidobacterium bifidum and B. breve species exhibit the greatest ability to degrade and grow on HMOs. Altogether, these findings indicate that the bifidobacterial component of the human milk microbiota is not strictly correlated with their ability to metabolize HMOs. © FEMS 2020.Entities:
Keywords: zzm321990 Bifidobacteriumzzm321990 ; HMOs; human milk; microbiota
Mesh:
Substances:
Year: 2020 PMID: 32188978 DOI: 10.1093/femsec/fiaa049
Source DB: PubMed Journal: FEMS Microbiol Ecol ISSN: 0168-6496 Impact factor: 4.194